What is the price target for 1VKTX stock?
24 analysts have analysed 1VKTX.MI and the average price target is 80.76 EUR. This implies a price increase of 223.96% is expected in the next year compared to the current price of 24.93.
VIKING THERAPEUTICS INC (1VKTX.MI) Forecast, Price Target & Analyst Ratings
BIT:1VKTX • US92686J1060
Current stock price
24.93 EUR
-0.3 (-1.17%)
Last:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for VIKING THERAPEUTICS INC (1VKTX.MI).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- Apr 21, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -$1.13
- Revenue Estimate
Price Target Details & History
Consensus Price Target and Range
Mean target
€80.76
Upside
+ 223.96%
From current price of €24.93 to mean target of €80.76, Based on 24 analyst forecasts
Low
€29.91
Median
€86.30
High
€111.04
Price Target Revisions
1 Month
-1.03%
3 Months
-2.20%
Price Target Summary
24 Wall Street analysts provided a forecast for the next 12 months for 1VKTX.MI. The average price target is 80.76 EUR. This implies a price increase of 223.96% is expected in the next year compared to the current price of 24.93.
The average price target has been revised downward by 2.2% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
85.83%
1VKTX.MI was analyzed by 24 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about 1VKTX.MI.
In the previous month the buy percentage consensus was at a similar level.
1VKTX.MI was analyzed by 24 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
Recent Upgrades & Downgrades
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- Apr 21, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -$1.13
- Revenue Estimate
- Revenue Q2Q
- N/A
- EPS Q2Q
- -175.94%
- Number of Analysts
- 16
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
-18.56%
EPS (3 Months)
-17.46%
Next Earnings Summary
1VKTX.MI is expected to report earnings on 4/21/2026. The consensus EPS estimate for the next earnings is -1.13 EUR and the consensus revenue estimate is 0 EUR.
Full Analyst Estimates 2026 - 2033
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A -100.00% | N/A | N/A 213.75% | N/A 166.95% | N/A 81.12% | N/A 53.69% | N/A 44.77% | ||||||||||||
| EBITDA YoY % growth | N/A | N/A | N/A | N/A | N/A -21.76% | N/A -30.72% | N/A -38.37% | N/A -17.68% | -100.535M -45.16% | -150.575M -49.77% | N/A -119.21% | N/A -75.50% | N/A -12.40% | N/A 7.67% | N/A 29.13% | N/A 126.78% | N/A 466.73% | N/A 96.54% | N/A 65.62% | |
| EBIT YoY % growth | -12M | -13.85M -15.42% | -19.07M -37.69% | -26.16M -37.18% | -32.69M -24.96% | -42.66M -30.50% | -55.68M -30.52% | -70.36M -26.36% | -100.827M -43.30% | -150.921M -49.68% | -393.342M -160.63% | N/A -32.22% | N/A -11.89% | N/A 2.94% | N/A 36.48% | N/A 185.81% | N/A 302.46% | N/A 95.56% | N/A 72.80% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | -3.56 | -1.00 71.91% | -0.80 20.00% | -0.39 51.25% | -0.36 7.69% | -0.54 -50.00% | -0.72 -33.33% | -0.91 -26.39% | -0.92 -1.10% | -1.00 -8.70% | -3.18 -218.00% | N/A -19.40% | N/A -9.77% | N/A 8.06% | N/A 67.32% | N/A 453.42% | N/A 154.75% | N/A 75.24% | N/A 60.54% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -1.13 -175.94% | -1.14 -96.53% | -1.03 -26.91% | -1.10 20.07% | -0.98 13.45% | -0.97 14.99% | -0.97 5.73% | -1.17 -6.34% |
| Revenue Q2Q % growth | N/A | N/A | N/A | N/A | ||||
| EBITDA Q2Q % growth | -149.816M -170.63% | -140.905M -89.51% | -93.539M -13.64% | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -129.348M -133.19% | -129.123M -73.15% | -120.097M -21.85% | -137.432M 16.58% | N/A | N/A | N/A | N/A |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
-6.42%
EPS Next 5 Year
27.67%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
-20.98%
EBIT Next 5 Year
18.49%
VIKING THERAPEUTICS INC / 1VKTX.MI Forecast FAQ
When does VIKING THERAPEUTICS INC (1VKTX.MI) report earnings?
VIKING THERAPEUTICS INC (1VKTX.MI) will report earnings on 2026-04-21, after the market close.
What are the consensus estimates for VIKING THERAPEUTICS INC (1VKTX.MI) next earnings?
The consensus EPS estimate for the next earnings of VIKING THERAPEUTICS INC (1VKTX.MI) is -1.13 EUR and the consensus revenue estimate is 0 EUR.